Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

FDA approves Wilate for hemophilia A

Oct. 9, 2019

Discovery of novel potent fully human FVIII mimetic BiAb, KY-1049

Oct. 9, 2019

BARDA contract supports Platelet BioGenesis' development of donor-independent platelets

Oct. 8, 2019

Phase I study of CSL-200 gene therapy in adults with severe sickle cell disease

Oct. 3, 2019

Neurotransmitter receptor stimulates early blood cell progenitors

Oct. 2, 2019

Japanese approval for Evrenzo for anemia associated with chronic kidney disease in dialysis patients

Sep. 20, 2019

Inflammation stress induces red blood cell formation

Sep. 18, 2019

Edoxaban in atrial fibrillation patients after PCI: Results from ENTRUST-AF PCI

Sep. 17, 2019

Pharvaris announces financing to advance clinical development of HAE oral therapy

Sep. 13, 2019

First safety data presented from phase II trial of revacept

Sep. 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.